Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Safety and Efficacy of Axicabtagene Ciloleucel (Axi-Cel) in Older Patients: Results From the Us Lymphoma Car-T Consortium

Hematological Oncology

English

Oral Azacytidine (Aza) and Romidepsin (R) Reveals Promising Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

Hematological Oncology

English

A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (Apvd) for Patients With Untreated Classical Hodgkin Lymphoma

Hematological Oncology

English

What Can We Learn Regarding Immunotherapy From Malignant Melanoma

Hematological Oncology

English

MELK Serves as a Potent Independent Biomarker to Predict Survival of Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-Chop Regimen

Hematological Oncology

English

Defining Burkitt-Like Lymphoma With 11q Aberration in a Specialised Uk Haematopathology Diagnostic Service

Hematological Oncology

English

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients With Diffuse Large B-Cell Lymphoma (Cisl 1403)

Hematological Oncology

English

Is It Radiotherapy Necessary for Primary Mediastinal B-Cell Lymphoma (Pmbl) Patients Achieving Pet Negativity After Immunochemotherapy?

Hematological Oncology

English

High Efficacy of Venetoclax Plus Obinutuzumab in Patients With Complex Karyotype (Ckt) and Chronic Lymphocytic Leukemia (Cll): A Prospective Analysis From the Cll14 Trial

Hematological Oncology

English

LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: A LYSA STUDY

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Safety and Efficacy of Axicabtagene Ciloleucel (Axi-Cel) in Older Patients: Results From the Us Lymphoma Car-T Consortium

Oral Azacytidine (Aza) and Romidepsin (R) Reveals Promising Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (Apvd) for Patients With Untreated Classical Hodgkin Lymphoma

What Can We Learn Regarding Immunotherapy From Malignant Melanoma

MELK Serves as a Potent Independent Biomarker to Predict Survival of Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-Chop Regimen

Defining Burkitt-Like Lymphoma With 11q Aberration in a Specialised Uk Haematopathology Diagnostic Service

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients With Diffuse Large B-Cell Lymphoma (Cisl 1403)

Is It Radiotherapy Necessary for Primary Mediastinal B-Cell Lymphoma (Pmbl) Patients Achieving Pet Negativity After Immunochemotherapy?

High Efficacy of Venetoclax Plus Obinutuzumab in Patients With Complex Karyotype (Ckt) and Chronic Lymphocytic Leukemia (Cll): A Prospective Analysis From the Cll14 Trial

LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: A LYSA STUDY